[1]
2024. Molecular Docking and Drug Kinetics Assessment for Structure-Based Drug Design of New Piperazine-Containing Hydrazone Derivatives as Effective Alzheimer Inhibitors. Journal of Biochemistry, Microbiology and Biotechnology. 12, 2 (Dec. 2024), 37–43. DOI:https://doi.org/10.54987/jobimb.v12i2.1016.